Further references used to develop this protocol:
Metcalfe, K. A., A. Finch, A. Poll, et al. 2009. "Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation." Br J Cancer 100(2):421-425
Kurian, A. W., B. M. Sigal and S. K. Plevritis. 2010. "Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers." J Clin Oncol 28(2):222-231
Shuster, L. T., B. S. Gostout, B. R. Grossardt, et al. 2008. "Prophylactic oophorectomy in premenopausal women and long-term health." Menopause Int 14(3):111-116
Randall, D., S. Morrell, R. Taylor, et al. 2009. "Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia." Cancer Causes Control 20(5):559-566
Jacobi, C. E., N. J. Nagelkerke, J. H. van Houwelingen, et al. 2006. "Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study." Cancer Epidemiol Biomarkers Prev 15(3):429-436.
FH01 collaborative teams. 2010. "Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study." Lancet Oncol 11(12):1127-1134
Berg, W. A., J. D. Blume, J. B. Cormack, et al. 2008. "Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer." JAMA 299(18):2151-2163
Warner, E., H. Messersmith, P. Causer, et al. 2008. "Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer." Ann Intern Med 148(9):671-679.
Vogel, V. G., J. P. Costantino, D. L. Wickerham, et al. 2006. "Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial." Jama 295(23):2727-2741
Goss, P. E., J. N. Ingle, J. E. Ales-Martinez, et al. 2011. "Exemestane for breast-cancer prevention in postmenopausal women." N Engl J Med 364(25):2381-2391
Kuhl CK. Schrading S. Leutner CC. Morakkabati-Spitz N. Wardelmann E. Fimmers R. Kuhn W. Schild HH. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 23(33):8469-76, 2005 Nov
Vogel VG. Costantino JP. Wickerham DL. Cronin WM. Cecchini RS. Atkins JN. Bevers TB. Fehrenbacher L. Pajon ER. Wade JL 3rd. Robidoux A. Margolese RG. James J. Runowicz CD. Ganz PA. Reis SE. McCaskill-Stevens W. Ford LG. Jordan VC. Wolmark N. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer. National Surgical Adjuvant Breast and Bowel Project. Cancer Prevention Research. 3(6):696-706, 2010 Jun.
Cuzick J. Forbes JF. Sestak I. Cawthorn S. Hamed H. Holli K. Howell A. Long-term results of tamoxifen prophylaxis for breast cancer 96-month follow-up of the randomized IBIS-I trial. International Breast Cancer Intervention Study I Investigators. Journal of the National Cancer Institute. 99(4):272-82, 2007 Feb 21.